Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2026-01-16 @ 1:34 AM
Study NCT ID:
NCT03430518
Status:
COMPLETED
Last Update Posted:
2020-08-05
First Post:
2018-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer
Sponsor:
Organization: